KEYTRUDA Plus LENVIMA Significantly Reduced Risk of Disease Progression or Death by 61% Versus Sunitinib, With a Median PFS of Nearly Two Years Versus Nine Months for Sunitinib LENVIMA Plus Everolimus Significantly Improved PFS and Objective Response Rate Versus Sunitinib First Results From Pivotal CLEAR Study Presented at 2021 Genitourinary Cancers Symposium and Published in the New England Journal of Medicine … KEYTRUDA Plus LENVIMA Significantly Reduced Risk of Disease Progression or Death by 61% Versus Sunitinib, With a Median PFS of Nearly Two Years Versus Nine Months for Sunitinib LENVIMA Plus Everolimus Significantly Improved PFS and Objective Response Rate Versus Sunitinib First Results From Pivotal CLEAR Study (KEYNOTE-581/Study 307) Presented at 2021 Genitourinary Cancers Symposium (ASCO GU) and Published in the New England Journal of Medicine
Updated Feb 05, 2021 | 07:15 IST
Misinformation about cancer and myths that surround it can make it difficult to spread awareness, and get people to get tested and treated for the disease. Cancer awareness is key for early detection: Common misconceptions about cancer and its treatment | Photo Credit: iStock Images
New Delhi: Cancer is one of the most deadly diseases that affect millions of people around the world. World Cancer Day is observed on the 4th of February, every year. The day aims to raise awareness about the disease and provide means for early diagnosis of cancer. Early detection of cancer is one of the most important events for cancer treatment. When cancer is identified before it spreads within the organ, or even to other organs of the body, it is easier to treat, and chances of successful treatment and survival increase. However, misinformation about the disease and myths that surround it can make it difficult to spread awarenes
Fecal transplant overcomes resistance to immunotherapy in melanoma patients
Researchers at UPMC Hillman Cancer Center and the National Cancer Institute (NCI) demonstrate that changing the gut microbiome can transform patients with advanced melanoma who never responded to immunotherapy-;which has a failure rate of 40% for this type of cancer-;into patients who do.
The results of this proof-of-principle phase II clinical trial were published online today in
Science. In this study, a team of researchers from UPMC Hillman administered fecal microbiota transplants (FMT) and anti-PD-1 immunotherapy to melanoma patients who had failed all available therapies, including anti-PD-1, and then tracked clinical and immunological outcomes. Collaborators at NCI analyzed microbiome samples from these patients to understand why FMT seems to boost their response to immunotherapy.
World Cancer Day: After battling Covid, hospitals to draw focus back on cancer
By
Ashish Srivastava ( IANS) |
Published on
Thu, Feb 4 2021 17:33 IST |
0 Views
Cancer.. Image Source: IANS
New Delhi, Feb 4 : The Covid-19 pandemic has taken a toll on timely diagnosis and treatment of chronic diseases, and preventive care for ailments like cancer is one of the worst hit.
However, since the cases of Covid-19 have started to subside gradually, the need for awareness among the patients has multiplied. In lieu of it, the hospitals have geared up to start awareness campaigns to draw patients attention back on cancer treatment.
Suresh Kumar, Director at Delhi s Lok Nayak Hospital, told IANS that the hospital will start an awareness campaign specifically for cancer patients.
Kanserde doğru tanı tedaviyi hızlandırıyor ensonhaber.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ensonhaber.com Daily Mail and Mail on Sunday newspapers.